scispace - formally typeset
M

Matthew Law

Researcher at Kirby Institute

Publications -  717
Citations -  43943

Matthew Law is an academic researcher from Kirby Institute. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 89, co-authored 668 publications receiving 40044 citations. Previous affiliations of Matthew Law include Queensland University of Technology & Mahidol University.

Papers
More filters
Journal ArticleDOI

Adjuvant psychological therapy for patients with cancer: Outcome at one year

TL;DR: It is demonstrated that a brief psychological intervention can produce improvement in psychological functioning which persists up to 10 months after the end of the intervention; in particular, the number of patients who would still meet criteria for ‘caseness’ is reduced.
Journal ArticleDOI

Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study†

TL;DR: The aim of the study was to assess the impact of the gain in body mass index observed immediately after antiretroviral therapy (ART) initiation on the subsequent risk of cardiovascular disease (CVD) and diabetes.
Journal ArticleDOI

Predictors of Hypertension and Changes of Blood Pressure in HIV-Infected Patients:

TL;DR: In this paper, the authors assessed predictors of changes in systolic (SBP) and diastolic (DBP) blood pressure during follow-up and of the development of hypertension in HIV-infected individuals.
Journal ArticleDOI

Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: A Mendelian randomisation analysis

Daniel F. Freitag, +158 more
TL;DR: In this paper, a genetic score combining the effects of alleles of two common variants (rs6743376 and rs1542176) that are located upstream of IL1RN, the gene encoding the IL-1 receptor antagonist (IL-1Ra; an endogenous inhibitor of both IL 1 alpha and IL 1 beta) was created to investigate potential cardiovascular and other effects of long-term pharmacological interleukin 1 inhibition.
Journal ArticleDOI

Effectiveness of needle and syringe programmes for preventing HIV transmission

TL;DR: The study provides additional evidence that NSPs reduce transmission of HIV infection as the rapid spread of HIV among IDU populations and increasing rates of injecting in many countries calls for scaling up of N SPs as well as other harm reduction strategies.